After 30 years under local ownership, a Rochester prosthetic firm has been bought out by an Austin, Texas-based company.
Prosthetic Laboratories of Rochester, Inc., founded here by former Mayo Clinic technicians Steve Amundson and Mike Gozola in 1984, has been acquired by Hanger Inc.
Darren Overton of Prosthetic Labs confirmed the sale, but didn't say when it occurred or what it might mean for the about 85 employees that work at Prosthetic Lab's offices in Minnesota, Wisconsin and South Dakota.
"We aren't at liberty to disclose details of the acquisition, but what we can share is that we are pleased our company has joined the Hanger family," he stated in an email response to questions. "Hanger provides more opportunities and resources to our staff and patients than we could as an independent facility."
A media representative for Hanger said they could not discuss the purchase yet. The publicly traded company describes itself as the largest owner and operator of orthotic and prosthetic patient care clinics in the United States.
In 2009, the majority owner of Prosthetic Labs was Rochester developer Gus Chafoulias. He owned the private company along with Gozola and Amundson. It's unclear if those three were still the owners, when Hangar bought the firm.
Its main Rochester facility is located at 121 23rd Ave. S.W., in front of the Shorewood Senior Campus along Second Street Southwest. Prosthetic Labs' corporate family also includes Lair’s Shoes, the Silhouette Shoppe and Ortho Innovations. Its staff saw an average of 10,000 patients a year at its Rochester office in 2009.
While Prosthetic Labs has been very successful locally, it's much smaller than its new new owner. Hanger reports that it has an annual net income of about $60 million and makes about $1 billion of sales a year. It has more than 5,000 employees working at 740 clinic locations.
Acquiring mid-sized firms like Prosthetic Labs is not a new thing for Hanger. In 2012, it bought six companies.
In May, Hanger reported earnings for the first quarter that did not rise to the levels analysts had expected. The company reported an earning per share of 19 cents, missing the estimate of 24 cents. Its quarterly revenue of $235.60 million was below the anticipated $243.60 million